Circulating Tumor DNA as Marker for Response to Antineoplastic Treatment of Metastatic Cancer (FLUIDO)
Clinical trial NCT04793061 · UNKNOWN
Trial details
- NCT number
- NCT04793061
- Sponsor
- Elisabethinen Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-01
- Primary completion
- 2022-06-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.